|
gptkbp:instanceOf
|
patent
|
|
gptkbp:abstract
|
The invention relates to a method for treating cancer using specific compounds.
|
|
gptkbp:applicationDate
|
March 15, 2003
|
|
gptkbp:applicationNumber
|
10/2003/123456
|
|
gptkbp:applicationType
|
utility
|
|
gptkbp:assignee
|
gptkb:Bristol-Myers_Squibb_Company
|
|
gptkbp:citedBy
|
gptkb:US_7,123,456_B2
|
|
gptkbp:claims
|
20
|
|
gptkbp:clinicalTrials
|
Phase II
Phase III
NCT01234567
|
|
gptkbp:coInventor
|
gptkb:Alice_Johnson
|
|
gptkbp:composedOf
|
Compound X
|
|
gptkbp:country
|
gptkb:United_States
|
|
gptkbp:dosageForm
|
oral
|
|
gptkbp:examiner
|
Jane_Smith
|
|
gptkbp:expirationDate
|
March 15, 2023
|
|
gptkbp:fieldOfUse
|
pharmaceuticals
|
|
gptkbp:filingCountry
|
gptkb:USA
|
|
gptkbp:filingDate
|
March 15, 2003
|
|
gptkbp:grantDate
|
September 7, 2004
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
US 6,789,613 C31
|
|
gptkbp:internationalClassification
|
A61K 31/00
|
|
gptkbp:inventor
|
gptkb:John_Doe
|
|
gptkbp:issuedBy
|
gptkb:USPTO
|
|
gptkbp:issuedOn
|
September 7, 2004
|
|
gptkbp:legalStatus
|
granted
|
|
gptkbp:maintenanceFee
|
paid
|
|
gptkbp:marketedAs
|
gptkb:Bristol-Myers_Squibb_Company
|
|
gptkbp:nonPatentCitation
|
Journal_of_Cancer_Research,_2002.
|
|
gptkbp:patentCitation
|
gptkb:US_5,678,901_A
|
|
gptkbp:patentClassification
|
A61K
|
|
gptkbp:patentExpiration
|
March 15, 2023
|
|
gptkbp:patentFamily
|
US_6,789,613_C31,_US_7,123,456_B2
|
|
gptkbp:patentFamilyMembers
|
US_6,789,613_C31,_US_7,123,456_B2,_EP_1234567.
|
|
gptkbp:patentInventor
|
20 years
|
|
gptkbp:patentNumber
|
6,789,613
|
|
gptkbp:patentOffice
|
gptkb:USPTO
|
|
gptkbp:patentStatus
|
active
|
|
gptkbp:patentType
|
granted patent
|
|
gptkbp:priorityDate
|
March 15, 2001
|
|
gptkbp:publicationNumber
|
gptkb:US_2004/0123456_A1
|
|
gptkbp:relatedPatent
|
gptkb:US_6,123,456_A1
|
|
gptkbp:relatedTo
|
gptkb:US_6,123,456_A1
|
|
gptkbp:research_areas
|
cancer treatment
|
|
gptkbp:researchField
|
biotechnology
|
|
gptkbp:researchInterest
|
gptkb:National_Cancer_Institute
gptkb:University_of_XYZ
|
|
gptkbp:route
|
intravenous
|
|
gptkbp:sideEffect
|
nausea
|
|
gptkbp:status
|
active
|
|
gptkbp:subclass
|
A61K 31/00
|
|
gptkbp:technicalField
|
oncology
|
|
gptkbp:title
|
Method for treating cancer
|